InsidersTradesSigma
Track the 네오팜 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 네오팜 has logged 23 public disclosures. Market capitalisation: €295.9bn. The latest transaction was reported on 5 March 2026 (Purchase). Among the most active insiders: 잇츠한불. The full history is free.
23
Insider Decl.
n/a
Thresholds
€2m
18 ops.
Buy Volume
n/a
n/a
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 719 of 29,063 companies
83.0
score / 100
Value79
Quality87
FCF yld9.1%
Earn yld9.4%
EV/EBITDA8.4x
ROE·
Gross mgn65%
Net mgn21%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 5 March 2026
Declarations23 total
164,396 sharesKRXDART:20260305000589
803,389 sharesKRXDART:20260202000117
23 of 23 declarations
Acerca de 네오팜
Neopharm es una empresa especializada en el sector sanitario y farmacéutico. Cotiza en el mercado XKRX.